ThreoTech reaches patent infringement dispute settlement with doTerra over Magtein magnesium L-theronate.
Image | adobe.stock/Ulf
In a recent press release, ThreoTech, LLC (ThreoTech), announced that the company had reached a confidential settlement with doTerra. The settlement ends a patent infringement dispute regarding ThreoTech’s Magtein magnesium L-theronate nutritional supplement.
“Magtein is a unique dietary supplement ingredient protected by a variety of composition and use patents,” said Edward Lee, CEO of ThreoTech, LLC, in a press release. “Our patent portfolio and other intellectual property supporting Magtein magnesium L-threonate is strong. We stand ready to protect our intellectual property.”
This isn’t the first patent infringement dispute involving Magtein. In December 20241, ThreoTech LLC announced that the company reached a confidential settlement with Green Jeeva.
Reference